To Get More Information on Women’s Hormonal Supplements Market - Request Sample Report
The Women’s Hormonal Supplements Market Size was valued at USD 4.50 Billion in 2023, and is expected to reach USD 8.50 Billion by 2032, and grow at a CAGR of 7.6% over the forecast period 2024-2032.
The Hormonal Balance Supplements Market is experiencing significant growth which leads to a boost in the prevalence of hormonal disorders including polycystic ovary syndrome (PCOS), thyroid disorder, and menopause issues. Health stats accentuate the problems and underscore the need for serious solutions from the government.
The Centers for Disease Control and Prevention (CDC) states that around 10% of women aged between 15-44 years are affected by polycystic ovary syndrome (PCOS). A hormonal condition that can be associated with an irregular menstrual cycle, lack of ovulation (so difficulty getting pregnant), and risk factors for type II diabetes including insulin resistance. This high prevalence of PCOS in women indicates an urgent need for dietary supplements to help alleviate these symptoms and improve the quality of life.
Thyroid disorders are another big worry with the American Thyroid Association saying that as many as 20 million Americans have a kind of thyroid disease. But fall is also when I begin to see more women with ailing thyroids, which are five to eight times less efficient than men's. Thyroid disorders such as hypothyroidism and hyperthyroidism have numerous symptomatic manifestations, including weight changes, fatigue, and mood issues; thus, their proper management is essential. Not just that support helps, supplements containing iodine, selenium, and other important nutrient function boosters for thyroids have gained a lot of popularity these days.
Symptoms associated with menopause are a major factor driving the market for hormonal balance supplements. In the United States, an estimated 1.3 million women enter menopause annually as per North America Menopause Society. This phase comes with symptoms of hot flashes, night sweats, and mood swings; however, they also bring thin bones. Symptoms may be so severe that many turn to supplements in order not to suffer too much and still stay healthy throughout this time of life.
To sum up middle age and especially post menopause stage, most women are getting vulnerable to PCOS and thyroid problems leading many of them to consider Hormonal balance supplements. This growing disease burden highlights the need for ongoing innovation and investment in this space addressing an ever-growing segment of women who are looking to amend these conditions with a better mode of effective relief.
KEY DRIVERS:
Growing Awareness About Women's Health Issues, Including Hormonal Imbalances, Menstrual Health, And Menopause, Is Driving Demand for Specialized Supplements.
The Increasing Incidence of Hormonal Disorders Such as Polycystic Ovary Syndrome (PCOS), Thyroid Disorders, And Menopause-Related Issues Is Driving the Market for Hormonal Balance Supplements.
RESTRAINTS:
The Stringent Regulatory Environment for Dietary Supplements, Including Hormonal Balance Products, Can Act as A Barrier to Market Entry and Expansion.
Concerns About the Safety and Efficacy of Hormonal Balance Supplements Can Hinder Market Growth.
OPPORTUNITY:
Innovations In Supplement Formulation, Such as The Use of Bioavailable Ingredients, Advanced Delivery Systems, And Personalized Nutrition, Offer Significant Growth Opportunities.
Tapping Into Emerging Markets in Regions Such as Asia-Pacific, Latin America, And the Middle East Presents Significant Growth Potential.
By Type
Vitamins and minerals had the highest market share regarding women's hormonal balance supplements in 2023, around 42%. The reasons behind this dominance are broad consumer knowledge, strong scientific evidence in favor of them, and government initiatives promoting healthiness. The NIH states that vitamin and mineral deficiencies among women are common, including B vitamins, Vitamin D, magnesium, and calcium which affect hormones. It is for this reason that the NIH has suggested a critical need to consume these nutrients in intake from dietary supplements. According to the U.S. Department of Health and Human Services (HHS), approximately half of the women in America have taken dietary supplements, with multivitamins being the most popular due to their overall perceived health benefits and nutrient contributions. Regulations on health supplement manufacturing like the U.S Dietary Supplement Health and Education Act (DSHEA) help protect consumers by providing a framework to ensure the safety and efficacy of these supplements which in turn boosts confidence. The ability to capitalize on consumer spending while possessing the credibility of science and regulatory approval rendered by vitamins and minerals this unique market positioning in women's hormonal balance supplements.
By Consumer Group
The menopausal women consumer group accounted for the largest proportion of sales within the women's hormonal balance supplements industry which is 51%. There is an Increased Global Aging Women Population which is responsible for Increased Menopause population. This has caused significant demand in this segment. The World Health Organization (WHO) predicts that by 2030, there will be around 1.2 billion postmenopausal women across the globe and a large proportion of them experience symptoms such as hot flushes/flashers, night sweats, mood swings etc. Other governments and health agencies have been working to improve awareness of menopause, urging women to adopt good nutrition habits when managing symptoms like these. In the United States, as an example: The National Institutes of Health (NIH) has sponsored a major body of research on menopause, focusing attention on quality-of-life issues surrounding hormonal balance. This increase in awareness combined with the significant population of women who fall into menopausal age categories is expected to fuel sales for supplemental products targeting symptoms experienced during this time, thus positioning this consumer group as being among the top consumer segment of hormonal balance supplements by 2023.
By Indication
The largest market share was held by the segment for Menopause Relief, in 2023, within the women's hormonal balance supplements market. More than 1.3 million women entering menopause annually in the United States have sparked surging demand for products that offer relief from symptoms like hot flashes, night sweats, and mood swings; according to health statistics gathered by the U.S. government. The North American Menopause Society (NAMS) states that approximately 80% of women undergoing menopause exhibit these symptoms, fueling the need for safe treatments. This demographic change along with improvement in perceptions and the acceptance of menopause as a serious health concern, has created a large market for supplements that have been designed to address these symptoms specifically. Meanwhile, according to the National Institutes of Health (NIH), there is a trend towards using natural and alternative therapies instead of hormone replacement therapy (HRT), enhancing use in Menopause Relief. This market-leading position is further backed by significant marketing and consumer education, along with continued product innovation that appeals to the growing ranks of health-seeking menopausal women who increasingly expect effective relief for their symptoms without many of the risks recognized as associated with synthetics.
North America was the foremost regional market for women’s hormonal balance supplements in 2023. It accounted for a substantial 35% share due to the high awareness level, established healthcare infrastructure, and strong spending power of the consumers. The U.S. Department of Health and Human Services estimates that about 80% of American women take dietary supplements. Dietary products are broadly accepted and incorporated into women’s daily health regimens. Besides, the U.S. Centers for Disease Control and Prevention reports that about 20% of women in the U.S. undergo menopause every year. It creates demand for menopausal relief supplements. Tight regulatory measures, such as regulatory agencies like the Food and Drug Administration, ensure that supplements are safe and effective for consumers. Rising health awareness and more proactive approaches to health management, combined with comprehensive public health education programs, have resulted in the following healthy demand for women’s hormonal balance supplements in the market.
Do You Need any Customization Research on Women’s Hormonal Supplements Market - Enquire Now
The key market players include Nature Made, Garden of Life, Nature's Way, Now Foods, Blackmores, Swisse Wellness, Vitabiotics, Church & Dwight, Bayer, Pfizer and other players.
Herbalife launched in February 2024, the GLP-1 Nutrition Companion Product Combos Designed to Supplement the Nutrition Needs of Individuals Taking Weight-Loss Medications.
Nature's Bounty Launches a Brand Campaign to Bring Together its Total Product Offering and Bond on an Emotional Level with Consumers in June 2024 It's in the ‘Your Nature’ campaign to reframe the brand positioning for a new era in nutritional supplement marketing, centered around continual themes of positivity and soul-searching.
| Report Attributes | Details |
| Market Size in 2023 | US$ 4.50 Billion |
| Market Size by 2032 | US$ 8.50 Billion |
| CAGR | CAGR of 7.6% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Type (Vitamins and Minerals, Proteins and Amino Acids, Probiotics and Enzymes, Omega-3 Fatty Acids & Others) •By Consumer Group (Menopausal Women, Premenopausal Women, Postmenopausal Women & Women with Hormonal Imbalances) •By Indication (Hormonal Balance, Menopause Relief, PMS Management, Fertility Support, Weight Management & Sleep Improvement) •By Form (Tablets, Capsules, Powders, Liquid Drops & Gummies) •By Distribution Channel (Pharmacies and Drug Stores, Health and Beauty Stores, Supermarkets and Hypermarkets & Online Retail) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Nature Made, Garden of Life, Nature's Way, Now Foods, Blackmores, Swisse Wellness, Vitabiotics, Church & Dwight, Bayer, Pfizer and other players |
| Key Drivers | •Growing Awareness About Women's Health Issues, Including Hormonal Imbalances, Menstrual Health, And Menopause, Is Driving Demand for Specialized Supplements. •The Increasing Incidence of Hormonal Disorders Such as Polycystic Ovary Syndrome (PCOS), Thyroid Disorders, And Menopause-Related Issues Is Driving the Market for Hormonal Balance Supplements. |
| RESTRAINTS | •The Stringent Regulatory Environment for Dietary Supplements, Including Hormonal Balance Products, Can Act as A Barrier to Market Entry and Expansion. •Concerns About the Safety and Efficacy of Hormonal Balance Supplements Can Hinder Market Growth. |
Ans: The U.S. led the Women’s Hormonal Supplements Market in the North American region with the highest revenue share in 2023.
Ans: Factors such as the stringent regulatory environment for dietary supplements, including hormonal balance products, can act as a barrier to market entry and expansion as well as concerns about the safety and efficacy of Women’s Hormonal Supplements Market can hinder market growth.
Ans Tablets held the largest share in the Women’s Hormonal Supplements Market in 2023.
Ans: The expected CAGR of the Women’s Hormonal Supplements Market during the forecast period is 7.6%.
Ans: The Women’s Hormonal Supplements Market was valued at USD 4.50 Billion in 2023.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Industry Flowchart
3. Research Methodology
4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
5. Porter’s 5 Forces Model
6. Pest Analysis
7. Women’s Hormonal Supplements Market Segmentation, By Type
7.1 Introduction
7.2 Vitamins and Minerals
7.3 Proteins and Amino Acids
7.4 Probiotics and Enzymes
7.5 Omega-3 Fatty Acids
7.6 Others
8. Women’s Hormonal Supplements Market Segmentation, By Consumer Group
8.1 Introduction
8.2 Menopausal Women
8.3 Premenopausal Women
8.4 Postmenopausal Women
8.5 Women with Hormonal Imbalances
9. Women’s Hormonal Supplements Market Segmentation, By Form
9.1 Introduction
9.2 Tablets
9.3 Capsules
9.4 Powder
9.5 Liquid Drops
9.6 Gummies
10. Women’s Hormonal Supplements Market Segmentation, By Indication
10.1 Introduction
10.2 Hormonal Balance
10.3 Menopause Relief
10.4 PMS Management
10.5 Fertility Support
10.6 Weight Management
10.7 Sleep Improvement
11. Women’s Hormonal Supplements Market Segmentation, By Distribution Channel
11.1 Introduction
11.2 Pharmacies and Drug Stores
11.3 Health and Beauty Stores
11.4 Supermarkets and Hypermarkets
11.5 Online Retail
12. Regional Analysis
12.1 Introduction
12.2 North America
12.2.1 Trend Analysis
12.2.2 North America Women’s Hormonal Supplements Market By Country
12.2.3 North America Women’s Hormonal Supplements Market By Type
12.2.4 North America Women’s Hormonal Supplements Market By Consumer Group
12.2.5 North America Women’s Hormonal Supplements Market By Form
12.2.6 North America Women’s Hormonal Supplements Market, By Indication
12.2.7 North America Women’s Hormonal Supplements Market, By Distribution Channel
12.2.8 USA
12.2.8.1 USA Women’s Hormonal Supplements Market By Type
12.2.8.2 USA Women’s Hormonal Supplements Market By Consumer Group
12.2.8.3 USA Women’s Hormonal Supplements Market By Form
12.2.8.4 USA Women’s Hormonal Supplements Market, By Indication
12.2.8.5 USA Women’s Hormonal Supplements Market, By Distribution Channel
12.2.9 Canada
12.2.9.1 Canada Women’s Hormonal Supplements Market By Type
12.2.9.2 Canada Women’s Hormonal Supplements Market By Consumer Group
12.2.9.3 Canada Women’s Hormonal Supplements Market By Form
12.2.9.4 Canada Women’s Hormonal Supplements Market, By Indication
12.2.9.5 Canada Women’s Hormonal Supplements Market, By Distribution Channel
12.2.10 Mexico
12.2.10.1 Mexico Women’s Hormonal Supplements Market By Type
12.2.10.2 Mexico Women’s Hormonal Supplements Market By Consumer Group
12.2.10.3 Mexico Women’s Hormonal Supplements Market By Form
12.2.10.4 Mexico Women’s Hormonal Supplements Market, By Indication
12.2.10.5 Mexico Women’s Hormonal Supplements Market, By Distribution Channel
12.3 Europe
12.3.1 Trend Analysis
12.3.2 Eastern Europe
12.3.2.1 Eastern Europe Women’s Hormonal Supplements Market By Country
12.3.2.2 Eastern Europe Women’s Hormonal Supplements Market By Type
12.3.2.3 Eastern Europe Women’s Hormonal Supplements Market By Consumer Group
12.3.2.4 Eastern Europe Women’s Hormonal Supplements Market By Form
12.3.2.5 Eastern Europe Women’s Hormonal Supplements Market By Indication
12.3.2.6 Eastern Europe Women’s Hormonal Supplements Market, By Distribution Channel
12.3.2.7 Poland
12.3.2.7.1 Poland Women’s Hormonal Supplements Market By Type
12.3.2.7.2 Poland Women’s Hormonal Supplements Market By Consumer Group
12.3.2.7.3 Poland Women’s Hormonal Supplements Market By Form
12.3.2.7.4 Poland Women’s Hormonal Supplements Market By Indication
12.3.2.7.5 Poland Women’s Hormonal Supplements Market, By Distribution Channel
12.3.2.8 Romania
12.3.2.8.1 Romania Women’s Hormonal Supplements Market By Type
12.3.2.8.2 Romania Women’s Hormonal Supplements Market By Consumer Group
12.3.2.8.3 Romania Women’s Hormonal Supplements Market By Form
12.3.2.8.4 Romania Women’s Hormonal Supplements Market By Indication
12.3.2.8.5 Romania Women’s Hormonal Supplements Market, By Distribution Channel
12.3.2.9 Hungary
12.3.2.9.1 Hungary Women’s Hormonal Supplements Market By Type
12.3.2.9.2 Hungary Women’s Hormonal Supplements Market By Consumer Group
12.3.2.9.3 Hungary Women’s Hormonal Supplements Market By Form
12.3.2.9.4 Hungary Women’s Hormonal Supplements Market By Indication
12.3.2.9.5 Hungary Women’s Hormonal Supplements Market, By Distribution Channel
12.3.2.10 Turkey
12.3.2.10.1 Turkey Women’s Hormonal Supplements Market By Type
12.3.2.10.2 Turkey Women’s Hormonal Supplements Market By Consumer Group
12.3.2.10.3 Turkey Women’s Hormonal Supplements Market By Form
12.3.2.10.4 Turkey Women’s Hormonal Supplements Market By Indication
12.3.2.10.5 Turkey Women’s Hormonal Supplements Market, By Distribution Channel
12.3.2.11 Rest of Eastern Europe
12.3.2.11.1 Rest of Eastern Europe Women’s Hormonal Supplements Market By Type
12.3.2.11.2 Rest of Eastern Europe Women’s Hormonal Supplements Market By Consumer Group
12.3.2.11.3 Rest of Eastern Europe Women’s Hormonal Supplements Market By Form
12.3.2.11.4 Rest of Eastern Europe Women’s Hormonal Supplements Market By Indication
12.3.2.11.5 Rest of Eastern Europe Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3 Western Europe
12.3.3.1 Western Europe Women’s Hormonal Supplements Market By Country
12.3.3.2 Western Europe Women’s Hormonal Supplements Market By Type
12.3.3.3 Western Europe Women’s Hormonal Supplements Market By Consumer Group
12.3.3.4 Western Europe Women’s Hormonal Supplements Market By Form
12.3.3.5 Western Europe Women’s Hormonal Supplements Market By Indication
12.3.3.6 Western Europe Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.7 Germany
12.3.3.7.1 Germany Women’s Hormonal Supplements Market By Type
12.3.3.7.2 Germany Women’s Hormonal Supplements Market By Consumer Group
12.3.3.7.3 Germany Women’s Hormonal Supplements Market By Form
12.3.3.7.4 Germany Women’s Hormonal Supplements Market By Indication
12.3.3.7.5 Germany Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.8 France
12.3.3.8.1 France Women’s Hormonal Supplements Market By Type
12.3.3.8.2 France Women’s Hormonal Supplements Market By Consumer Group
12.3.3.8.3 France Women’s Hormonal Supplements Market By Form
12.3.3.8.4 France Women’s Hormonal Supplements Market By Indication
12.3.3.8.5 France Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.9 UK
12.3.3.9.1 UK Women’s Hormonal Supplements Market By Type
12.3.3.9.2 UK Women’s Hormonal Supplements Market By Consumer Group
12.3.3.9.3 UK Women’s Hormonal Supplements Market By Form
12.3.3.9.4 UK Women’s Hormonal Supplements Market By Indication
12.3.3.9.5 UK Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.10 Italy
12.3.3.10.1 Italy Women’s Hormonal Supplements Market By Type
12.3.3.10.2 Italy Women’s Hormonal Supplements Market By Consumer Group
12.3.3.10.3 Italy Women’s Hormonal Supplements Market By Form
12.3.3.10.4 Italy Women’s Hormonal Supplements Market By Indication
12.3.3.10.5 Italy Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.11 Spain
12.3.3.11.1 Spain Women’s Hormonal Supplements Market By Type
12.3.3.11.2 Spain Women’s Hormonal Supplements Market By Consumer Group
12.3.3.11.3 Spain Women’s Hormonal Supplements Market By Form
12.3.3.11.4 Spain Women’s Hormonal Supplements Market By Indication
12.3.3.11.5 Spain Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.12 Netherlands
12.3.3.12.1 Netherlands Women’s Hormonal Supplements Market By Type
12.3.3.12.2 Netherlands Women’s Hormonal Supplements Market By Consumer Group
12.3.3.12.3 Netherlands Women’s Hormonal Supplements Market By Form
12.3.3.12.4 Netherlands Women’s Hormonal Supplements Market By Indication
12.3.3.12.5 Netherlands Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.13 Switzerland
12.3.3.13.1 Switzerland Women’s Hormonal Supplements Market By Type
12.3.3.13.2 Switzerland Women’s Hormonal Supplements Market By Consumer Group
12.3.3.13.3 Switzerland Women’s Hormonal Supplements Market By Form
12.3.3.13.4 Switzerland Women’s Hormonal Supplements Market By Indication
12.3.3.13.5 Switzerland Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.14 Austria
12.3.3.14.1 Austria Women’s Hormonal Supplements Market By Type
12.3.3.14.2 Austria Women’s Hormonal Supplements Market By Consumer Group
12.3.3.14.3 Austria Women’s Hormonal Supplements Market By Form
12.3.3.14.4 Austria Women’s Hormonal Supplements Market By Indication
12.3.3.14.5 Austria Women’s Hormonal Supplements Market, By Distribution Channel
12.3.3.15 Rest of Western Europe
12.3.3.15.1 Rest of Western Europe Women’s Hormonal Supplements Market By Type
12.3.3.15.2 Rest of Western Europe Women’s Hormonal Supplements Market By Consumer Group
12.3.3.15.3 Rest of Western Europe Women’s Hormonal Supplements Market By Form
12.3.3.15.4 Rest of Western Europe Women’s Hormonal Supplements Market By Indication
12.3.3.15.5 Rest of Western Europe Women’s Hormonal Supplements Market, By Distribution Channel
12.4 Asia-Pacific
12.4.1 Trend Analysis
12.4.2 Asia-Pacific Women’s Hormonal Supplements Market By Country
12.4.3 Asia-Pacific Women’s Hormonal Supplements Market By Type
12.4.4 Asia-Pacific Women’s Hormonal Supplements Market By Consumer Group
12.4.5 Asia-Pacific Women’s Hormonal Supplements Market By Form
12.4.6 Asia-Pacific Women’s Hormonal Supplements Market By Indication
12.4.7 Asia-Pacific Women’s Hormonal Supplements Market, By Distribution Channel
12.4.8 China
12.4.8.1 China Women’s Hormonal Supplements Market By Type
12.4.8.2 China Women’s Hormonal Supplements Market By Consumer Group
12.4.8.3 China Women’s Hormonal Supplements Market By Form
12.4.8.4 China Women’s Hormonal Supplements Market By Indication
12.4.8.5 China Women’s Hormonal Supplements Market, By Distribution Channel
12.4.9 India
12.4.9.1 India Women’s Hormonal Supplements Market By Type
12.4.9.2 India Women’s Hormonal Supplements Market By Consumer Group
12.4.9.3 India Women’s Hormonal Supplements Market By Form
12.4.9.4 India Women’s Hormonal Supplements Market By Indication
12.4.9.5 India Women’s Hormonal Supplements Market, By Distribution Channel
12.4.10 Japan
12.4.10.1 Japan Women’s Hormonal Supplements Market By Type
12.4.10.2 Japan Women’s Hormonal Supplements Market By Consumer Group
12.4.10.3 Japan Women’s Hormonal Supplements Market By Form
12.4.10.4 Japan Women’s Hormonal Supplements Market By Indication
12.4.10.5 Japan Women’s Hormonal Supplements Market, By Distribution Channel
12.4.11 South Korea
12.4.11.1 South Korea Women’s Hormonal Supplements Market By Type
12.4.11.2 South Korea Women’s Hormonal Supplements Market By Consumer Group
12.4.11.3 South Korea Women’s Hormonal Supplements Market By Form
12.4.11.4 South Korea Women’s Hormonal Supplements Market By Indication
12.4.11.5 South Korea Women’s Hormonal Supplements Market, By Distribution Channel
12.4.12 Vietnam
12.4.12.1 Vietnam Women’s Hormonal Supplements Market By Type
12.4.12.2 Vietnam Women’s Hormonal Supplements Market By Consumer Group
12.4.12.3 Vietnam Women’s Hormonal Supplements Market By Form
12.4.12.4 Vietnam Women’s Hormonal Supplements Market By Indication
12.4.12.5 Vietnam Women’s Hormonal Supplements Market, By Distribution Channel
12.4.13 Singapore
12.4.13.1 Singapore Women’s Hormonal Supplements Market By Type
12.4.13.2 Singapore Women’s Hormonal Supplements Market By Consumer Group
12.4.13.3 Singapore Women’s Hormonal Supplements Market By Form
12.4.13.4 Singapore Women’s Hormonal Supplements Market By Indication
12.4.13.5 Singapore Women’s Hormonal Supplements Market, By Distribution Channel
12.4.14 Australia
12.4.14.1 Australia Women’s Hormonal Supplements Market By Type
12.4.14.2 Australia Women’s Hormonal Supplements Market By Consumer Group
12.4.14.3 Australia Women’s Hormonal Supplements Market By Form
12.4.14.4 Australia Women’s Hormonal Supplements Market By Indication
12.4.14.5 Australia Women’s Hormonal Supplements Market, By Distribution Channel
12.4.15 Rest of Asia-Pacific
12.4.15.1 Rest of Asia-Pacific Women’s Hormonal Supplements Market By Type
12.4.15.2 Rest of Asia-Pacific Women’s Hormonal Supplements Market By Consumer Group
12.4.15.3 Rest of Asia-Pacific Women’s Hormonal Supplements Market By Form
12.4.15.4 Rest of Asia-Pacific Women’s Hormonal Supplements Market By Indication
12.4.15.5 Rest of Asia-Pacific Women’s Hormonal Supplements Market, By Distribution Channel
12.5 Middle East & Africa
12.5.1 Trend Analysis
12.5.2 Middle East
12.5.2.1 Middle East Women’s Hormonal Supplements Market By Country
12.5.2.2 Middle East Women’s Hormonal Supplements Market By Type
12.5.2.3 Middle East Women’s Hormonal Supplements Market By Consumer Group
12.5.2.4 Middle East Women’s Hormonal Supplements Market By Form
12.5.2.5 Middle East Women’s Hormonal Supplements Market By Indication
12.5.2.6 Middle East Women’s Hormonal Supplements Market, By Distribution Channel
12.5.2.7 UAE
12.5.2.7.1 UAE Women’s Hormonal Supplements Market By Type
12.5.2.7.2 UAE Women’s Hormonal Supplements Market By Consumer Group
12.5.2.7.3 UAE Women’s Hormonal Supplements Market By Form
12.5.2.7.4 UAE Women’s Hormonal Supplements Market By Indication
12.5.2.7.5 UAE Women’s Hormonal Supplements Market, By Distribution Channel
12.5.2.8 Egypt
12.5.2.8.1 Egypt Women’s Hormonal Supplements Market By Type
12.5.2.8.2 Egypt Women’s Hormonal Supplements Market By Consumer Group
12.5.2.8.3 Egypt Women’s Hormonal Supplements Market By Form
12.5.2.8.4 Egypt Women’s Hormonal Supplements Market By Indication
12.5.2.8.5 Egypt Women’s Hormonal Supplements Market, By Distribution Channel
12.5.2.9 Saudi Arabia
12.5.2.9.1 Saudi Arabia Women’s Hormonal Supplements Market By Type
12.5.2.9.2 Saudi Arabia Women’s Hormonal Supplements Market By Consumer Group
12.5.2.9.3 Saudi Arabia Women’s Hormonal Supplements Market By Form
12.5.2.9.4 Saudi Arabia Women’s Hormonal Supplements Market By Indication
12.5.2.9.5 Saudi Arabia Women’s Hormonal Supplements Market, By Distribution Channel
12.5.2.10 Qatar
12.5.2.10.1 Qatar Women’s Hormonal Supplements Market By Type
12.5.2.10.2 Qatar Women’s Hormonal Supplements Market By Consumer Group
12.5.2.10.3 Qatar Women’s Hormonal Supplements Market By Form
12.5.2.10.4 Qatar Women’s Hormonal Supplements Market By Indication
12.5.2.10.5 Qatar Women’s Hormonal Supplements Market, By Distribution Channel
12.5.2.11 Rest of Middle East
12.5.2.11.1 Rest of Middle East Women’s Hormonal Supplements Market By Type
12.5.2.11.2 Rest of Middle East Women’s Hormonal Supplements Market By Consumer Group
12.5.2.11.3 Rest of Middle East Women’s Hormonal Supplements Market By Form
12.5.2.11.4 Rest of Middle East Women’s Hormonal Supplements Market By Indication
12.5.2.11.5 Rest of Middle East Women’s Hormonal Supplements Market, By Distribution Channel
12.5.3 Africa
12.5.3.1 Africa Women’s Hormonal Supplements Market By Country
12.5.3.2 Africa Women’s Hormonal Supplements Market By Type
12.5.3.3 Africa Women’s Hormonal Supplements Market By Consumer Group
12.5.3.4 Africa Women’s Hormonal Supplements Market By Form
12.5.3.5 Africa Women’s Hormonal Supplements Market By Indication
12.5.3.6 Africa Women’s Hormonal Supplements Market, By Distribution Channel
12.5.3.7 Nigeria
12.5.3.7.1 Nigeria Women’s Hormonal Supplements Market By Type
12.5.3.7.2 Nigeria Women’s Hormonal Supplements Market By Consumer Group
12.5.3.7.3 Nigeria Women’s Hormonal Supplements Market By Form
12.5.3.7.4 Nigeria Women’s Hormonal Supplements Market By Indication
12.5.3.7.5 Nigeria Women’s Hormonal Supplements Market, By Distribution Channel
12.5.3.8 South Africa
12.5.3.8.1 South Africa Women’s Hormonal Supplements Market By Type
12.5.3.8.2 South Africa Women’s Hormonal Supplements Market By Consumer Group
12.5.3.8.3 South Africa Women’s Hormonal Supplements Market By Form
12.5.3.8.4 South Africa Women’s Hormonal Supplements Market By Indication
12.5.3.8.5 South Africa Women’s Hormonal Supplements Market, By Distribution Channel
12.5.3.9 Rest of Africa
12.5.3.9.1 Rest of Africa Women’s Hormonal Supplements Market By Type
12.5.3.9.2 Rest of Africa Women’s Hormonal Supplements Market By Consumer Group
12.5.3.9.3 Rest of Africa Women’s Hormonal Supplements Market By Form
12.5.3.9.4 Rest of Africa Women’s Hormonal Supplements Market By Indication
12.5.3.9.5 Rest of Africa Women’s Hormonal Supplements Market, By Distribution Channel
12.6 Latin America
12.6.1 Trend Analysis
12.6.2 Latin America Women’s Hormonal Supplements Market By country
12.6.3 Latin America Women’s Hormonal Supplements Market By Type
12.6.4 Latin America Women’s Hormonal Supplements Market By Consumer Group
12.6.5 Latin America Women’s Hormonal Supplements Market By Form
12.6.6 Latin America Women’s Hormonal Supplements Market By Indication
12.6.7 Latin America Women’s Hormonal Supplements Market, By Distribution Channel
12.6.8 Brazil
12.6.8.1 Brazil Women’s Hormonal Supplements Market By Type
12.6.8.2 Brazil Women’s Hormonal Supplements Market By Consumer Group
12.6.8.3 Brazil Women’s Hormonal Supplements Market By Form
12.6.8.4 Brazil Women’s Hormonal Supplements Market By Indication
12.6.8.5 Brazil Women’s Hormonal Supplements Market, By Distribution Channel
12.6.9 Argentina
12.6.9.1 Argentina Women’s Hormonal Supplements Market By Type
12.6.9.2 Argentina Women’s Hormonal Supplements Market By Consumer Group
12.6.9.3 Argentina Women’s Hormonal Supplements Market By Form
12.6.9.4 Argentina Women’s Hormonal Supplements Market By Indication
12.6.9.5 Argentina Women’s Hormonal Supplements Market, By Distribution Channel
12.6.10 Colombia
12.6.10.1 Colombia Women’s Hormonal Supplements Market By Type
12.6.10.2 Colombia Women’s Hormonal Supplements Market By Consumer Group
12.6.10.3 Colombia Women’s Hormonal Supplements Market By Form
12.6.10.4 Colombia Women’s Hormonal Supplements Market By Indication
12.6.10.5 Colombia Women’s Hormonal Supplements Market, By Distribution Channel
12.6.11 Rest of Latin America
12.6.11.1 Rest of Latin America Women’s Hormonal Supplements Market By Type
12.6.11.2 Rest of Latin America Women’s Hormonal Supplements Market By Consumer Group
12.6.11.3 Rest of Latin America Women’s Hormonal Supplements Market By Form
12.6.11.4 Rest of Latin America Women’s Hormonal Supplements Market By Indication
12.6.11.5 Rest of Latin America Women’s Hormonal Supplements Market, By Distribution Channel
13. Company Profiles
13.1 Nature Made
13.1.1 Company Overview
13.1.2 Financial
13.1.3 Types/ Services Offered
13.1.4 The SNS View
13.2 Garden of Life
13.2.1 Company Overview
13.2.2 Financial
13.2.3 Types/ Services Offered
13.2.4 The SNS View
13.3 Nature's Way
13.3.1 Company Overview
13.3.2 Financial
13.3.3 Types/ Services Offered
13.3.4 The SNS View
13.4 Now Foods
13.4.1 Company Overview
13.4.2 Financial
13.4.3 Types/ Services Offered
13.4.4 The SNS View
13.5 Blackmores
13.5.1 Company Overview
13.5.2 Financial
13.5.3 Types/ Services Offered
13.5.4 The SNS View
13.6 Swisse Wellness
13.6.1 Company Overview
13.6.2 Financial
13.6.3 Types/ Services Offered
13.6.4 The SNS View
13.7 Vitabiotics
13.7.1 Company Overview
13.7.2 Financial
13.7.3 Types/ Services Offered
13.7.4 The SNS View
13.8 Church & Dwight
13.8.1 Company Overview
13.8.2 Financial
13.8.3 Types/ Services Offered
13.8.4 The SNS View
13.9 Bayer
13.9.1 Company Overview
13.9.2 Financial
13.9.3 Types/ Services Offered
13.9.4 The SNS View
13.10 Pfizer
13.10.1 Company Overview
13.10.2 Financial
13.10.3 Types/ Services Offered
13.10.4 The SNS View
14. Competitive Landscape
14.1 Competitive Benchmarking
14.2 Market Share Analysis
14.3 Recent Developments
14.3.1 Industry News
14.3.2 Company News
14.3.3 Mergers & Acquisitions
15. Use Case and Best Practices
16. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segments
By Type
Vitamins and Minerals
Proteins and Amino Acids
Probiotics and Enzymes
Omega-3 Fatty Acids
Others
By Consumer Group
Menopausal Women
Premenopausal Women
Postmenopausal Women
Women with Hormonal Imbalances
By Indication
Hormonal Balance
Menopause Relief
PMS Management
Fertility Support
Weight Management
Sleep Improvement
By Form
Tablets
Powders
Capsules
Liquid Drops
Gummies
By Distribution Channel
Pharmacies and Drug Stores
Health and Beauty Stores
Supermarkets and Hypermarkets
Online Retail
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Amniotic Products Market size USD 0.84 Billion in 2023 and anticipated to grow USD 1.67 Billion by 2032, with compound annual growth rate 7.98% during the forecast period 2024-2032.
The Long-term Care Software Market Size was valued at USD 4968.12 million in 2023 and is expected to reach USD 8919.94 million by 2032 and grow at a CAGR of 6.74% over the forecast period 2024-2032.
The Diabetic Nephropathy Market size was valued at USD 2.33 Billion in 2023 and is expected to reach USD 3.72 Billion By 2031 and grow at a CAGR of 6.04% over the forecast period of 2024-2031.
Bone Graft and Substitutes Market was valued at USD 3.71 billion in 2023 and is projected to reach USD 6.74 billion by 2032, with a growing CAGR of 6.87%.
The Medical Terminology Software Market Size was valued at USD 1.25 billion in 2023 and is expected to reach USD 6.21 billion by 2032 and grow at a CAGR of 19.5% over the forecast period 2024-2032.
The Healthcare BPO Market Size was valued at USD 380.8 Bn in 2023 and is expected to reach USD 873.8 Bn by 2031 and grow at a CAGR of 9.71% by 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
